Membrane Repair Defects in Muscular Dystrophy Are Linked to Altered Interaction between MG53, Caveolin-3, and Dysferlin

被引:219
作者
Cai, Chuanxi [1 ]
Weisleder, Noah [1 ]
Ko, Jae-Kyun [1 ]
Komazaki, Shinji [3 ]
Sunada, Yoshihide [4 ]
Nishi, Miyuki [5 ]
Takeshima, Hiroshi [5 ]
Ma, Jianjie [1 ,2 ]
机构
[1] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Phys & Biophys, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Med, Piscataway, NJ 08854 USA
[3] Saitama Med Sch, Dept Anat, Saitama 3500495, Japan
[4] Kawasaki Med Sch, Dept Internal Med, Kurashiki, Okayama 7010192, Japan
[5] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068501, Japan
基金
美国国家卫生研究院;
关键词
MUTANT CAVEOLIN-3; SKELETAL-MUSCLE; T-TUBULE; OVEREXPRESSION; TRAFFICKING; MUTATIONS; APOPTOSIS; LIGAND; DAMAGE; HEART;
D O I
10.1074/jbc.M109.009589
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Defective membrane repair can contribute to the progression of muscular dystrophy. Although mutations in caveolin-3 (Cav3) and dysferlin are linked to muscular dystrophy in human patients, the molecular mechanism underlying the functional interplay between Cav3 and dysferlin in membrane repair of muscle physiology and disease has not been fully resolved. We recently discovered that mitsugumin 53 (MG53), a muscle-specific TRIM (Tri-partite motif) family protein (TRIM72), contributes to intracellular vesicle trafficking and is an essential component of the membrane repair machinery in striated muscle. Here we show that MG53 interacts with dysferlin and Cav3 to regulate membrane repair in skeletal muscle. MG53 mediates active trafficking of intracellular vesicles to the sarcolemma and is required for movement of dysferlin to sites of cell injury during repair patch formation. Mutations in Cav3 (P104L, R26Q) that cause retention of Cav3 in Golgi apparatus result in aberrant localization of MG53 and dysferlin in a dominant-negative fashion, leading to defective membrane repair. Our data reveal that a molecular complex formed by MG53, dysferlin, and Cav3 is essential for repair of muscle membrane damage and also provide a therapeutic target for treatment of muscular and cardiovascular diseases that are linked to compromised membrane repair.
引用
收藏
页码:15894 / 15902
页数:9
相关论文
共 34 条
[1]   Dysferlin and the plasma membrane repair in muscular dystrophy [J].
Bansal, D ;
Campbell, KP .
TRENDS IN CELL BIOLOGY, 2004, 14 (04) :206-213
[2]   Defective membrane repair in dysferlin-deficient muscular dystrophy [J].
Bansal, D ;
Miyake, K ;
Vogel, SS ;
Groh, S ;
Chen, CC ;
Williamson, R ;
McNeil, PL ;
Campbell, KP .
NATURE, 2003, 423 (6936) :168-172
[3]   MG53 Regulates Membrane Budding and Exocytosis in Muscle Cells [J].
Cai, Chuanxi ;
Masumiya, Haruko ;
Weisleder, Noah ;
Pan, Zui ;
Nishi, Miyuki ;
Komazaki, Shinji ;
Takeshima, Hiroshi ;
Ma, Jianjie .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (05) :3314-3322
[4]   MG53 nucleates assembly of cell membrane repair machinery [J].
Cai, Chuanxi ;
Masumiya, Haruko ;
Weisleder, Noah ;
Matsuda, Noriyuki ;
Nishi, Miyuki ;
Hwang, Moonsun ;
Ko, Jae-Kyun ;
Lin, Peihui ;
Thornton, Angela ;
Zhao, Xiaoli ;
Pan, Zui ;
Komazaki, Shinji ;
Brotto, Marco ;
Takeshima, Hiroshi ;
Ma, Jianjie .
NATURE CELL BIOLOGY, 2009, 11 (01) :56-U108
[5]   Differential effects of membrane and soluble Fas ligand on cardiomyocytes: role in ischemia/reperfusion injury [J].
Date, T ;
Mochizuki, S ;
Belanger, AJ ;
Yamakawa, M ;
Luo, ZY ;
Vincent, KA ;
Cheng, SH ;
Gregory, RJ ;
Jiang, CW .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2003, 35 (07) :811-821
[6]   Phenotypic variability associated with Arg26Gln mutation in caveolin3 [J].
Fee, DB ;
So, YT ;
Barraza, C ;
Figueroa, KP ;
Pulst, SM .
MUSCLE & NERVE, 2004, 30 (03) :375-378
[7]   Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype [J].
Galbiati, F ;
Volonté, D ;
Chu, JB ;
Li, M ;
Fine, SW ;
Fu, MF ;
Bermudez, J ;
Pedemonte, M ;
Weidenheim, KM ;
Pestell, RG ;
Minetti, C ;
Lisanti, MP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (17) :9689-9694
[8]   Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities [J].
Galbiati, F ;
Engelman, JA ;
Volonte, D ;
Zhang, XL ;
Minetti, C ;
Li, MM ;
Hou, H ;
Kneitz, B ;
Edelmann, W ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (24) :21425-21433
[9]   Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C) -: Retention of LGMD-1C caveolin-3 mutants within the Golgi complex [J].
Galbiati, F ;
Volonté, D ;
Minetti, C ;
Chu, JB ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (36) :25632-25641
[10]   Caveolae and caveolin-3 in muscular dystrophy [J].
Galbiati, F ;
Razani, B ;
Lisanti, MP .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (10) :435-441